Maze Therapeutics, Inc.
MAZEUnited States
6 filed reports · 224 financial concepts · 0 earnings calls · 0 media appearances
Filed reports
6 reports · Mar 2025 to Jun 2026Each report counts once it has at least one extracted financial fact.
| Report type | Reports | Facts | Periods |
|---|---|---|---|
| Quarterly · 10-QSEC EDGAR | 5 | 759 | Mar 2025 to Jun 2026 |
| Annual · 10-KSEC EDGAR | 1 | 430 | Dec 2025 |
Documents
Financial data
224 concepts · 1,189 factsEach concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.
Financial223 concepts · 1,179 facts · Sep 2019 to Jun 2026
- Adjustments to additional paid in capital sharebased compensation requisite service period recognition value12 · Mar 2024 to Jun 2026
- Allocated share based compensation expense12 · Mar 2024 to Jun 2026
- Cash and cash equivalents at carrying value12 · Mar 2024 to Jun 2026
- Cash cash equivalents restricted cash and restricted cash equivalents12 · Mar 2024 to Jun 2026
- Cash cash equivalents restricted cash and restricted cash equivalents period increase decrease excluding exchange rate effect12 · Mar 2024 to Jun 2026
- Depreciation12 · Mar 2024 to Jun 2026
- General and administrative expense (US GAAP)12 · Mar 2024 to Jun 2026
- Increase decrease in accounts payable12 · Mar 2024 to Jun 2026
- Increase decrease in operating lease liability12 · Mar 2024 to Jun 2026
- Increase decrease in other operating assets12 · Mar 2024 to Jun 2026
- Increase decrease in prepaid deferred expense and other assets12 · Mar 2024 to Jun 2026
- Interest and other income12 · Mar 2024 to Jun 2026
- Net cash provided by used in financing activities12 · Mar 2024 to Jun 2026
- Net cash provided by used in investing activities12 · Mar 2024 to Jun 2026
- Net cash provided by used in operating activities12 · Mar 2024 to Jun 2026
- Net income loss12 · Mar 2024 to Jun 2026
- Operating expenses (US GAAP)12 · Mar 2024 to Jun 2026
- Operating income loss12 · Mar 2024 to Jun 2026
- Operating lease expense12 · Mar 2024 to Jun 2026
- Other operating activities cash flow statement12 · Mar 2024 to Jun 2026
- Payments to acquire property plant and equipment12 · Mar 2024 to Jun 2026
- Proceeds from stock options exercised12 · Mar 2024 to Jun 2026
- Profit loss12 · Mar 2024 to Jun 2026
- Research and development expense12 · Mar 2024 to Jun 2026
Geography1 concepts · 10 facts · Mar 2024 to Jun 2026
- Revenue10 · Mar 2024 to Jun 2026
Segments
10 factsFigures broken down by business line, region, product or another axis the company reports on.
Statement geographical1 member · 10 facts
- US10 · Mar 2024 to Jun 2026
Text from filings
Management commentary and risk factors, extracted from SEC filings only.
No commentary or risk-factor text for this company.
Earnings calls
Transcripts with management claims and analyst questions, one per fiscal period.
No earnings-call transcripts for this company.
Executive media
Podcasts, interviews and conference appearances by the company's executives, with their claims.
No media appearances for this company.
Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Oct 16, 2026) and refreshed every few hours.